Poly Medicure Ltd
Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]
- Market Cap ₹ 15,256 Cr.
- Current Price ₹ 1,589
- High / Low ₹ 1,729 / 921
- Stock P/E 63.9
- Book Value ₹ 138
- Dividend Yield 0.19 %
- ROCE 18.9 %
- ROE 15.1 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 20.0% CAGR over last 5 years
Cons
- Stock is trading at 11.5 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
208 | 252 | 312 | 373 | 393 | 439 | 507 | 586 | 646 | 746 | 879 | 1,068 | 1,240 | |
162 | 199 | 238 | 288 | 307 | 345 | 386 | 452 | 483 | 536 | 665 | 797 | 906 | |
Operating Profit | 46 | 52 | 74 | 85 | 86 | 94 | 122 | 134 | 162 | 210 | 214 | 270 | 334 |
OPM % | 22% | 21% | 24% | 23% | 22% | 21% | 24% | 23% | 25% | 28% | 24% | 25% | 27% |
1 | 0 | 11 | 28 | 8 | 13 | 14 | 16 | 19 | 19 | 39 | 32 | 51 | |
Interest | 8 | 7 | 9 | 10 | 10 | 8 | 11 | 13 | 20 | 10 | 5 | 10 | 10 |
Depreciation | 10 | 12 | 14 | 18 | 20 | 23 | 28 | 36 | 39 | 46 | 53 | 56 | 61 |
Profit before tax | 29 | 34 | 62 | 84 | 65 | 76 | 96 | 100 | 122 | 173 | 195 | 237 | 314 |
Tax % | 33% | 29% | 31% | 27% | 27% | 26% | 27% | 34% | 24% | 25% | 25% | 24% | |
19 | 24 | 43 | 61 | 47 | 56 | 70 | 66 | 92 | 130 | 146 | 179 | 239 | |
EPS in Rs | 2.19 | 2.73 | 4.88 | 6.92 | 5.36 | 6.37 | 7.96 | 7.51 | 10.47 | 13.51 | 15.23 | 18.66 | 24.88 |
Dividend Payout % | 17% | 9% | 20% | 18% | 28% | 39% | 25% | 27% | 19% | 19% | 16% | 16% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 16% |
3 Years: | 18% |
TTM: | 22% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 20% |
3 Years: | 24% |
TTM: | 49% |
Stock Price CAGR | |
---|---|
10 Years: | 30% |
5 Years: | 49% |
3 Years: | 25% |
1 Year: | 69% |
Return on Equity | |
---|---|
10 Years: | 18% |
5 Years: | 16% |
3 Years: | 15% |
Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 22 | 22 | 22 | 44 | 44 | 44 | 44 | 48 | 48 | 48 | 48 |
Reserves | 82 | 100 | 122 | 170 | 202 | 225 | 290 | 336 | 385 | 906 | 1,029 | 1,186 | 1,277 |
46 | 49 | 67 | 76 | 79 | 97 | 127 | 150 | 194 | 126 | 111 | 137 | 128 | |
41 | 52 | 71 | 87 | 73 | 83 | 93 | 103 | 117 | 107 | 146 | 167 | 209 | |
Total Liabilities | 180 | 212 | 282 | 354 | 376 | 449 | 555 | 633 | 740 | 1,187 | 1,334 | 1,538 | 1,662 |
82 | 89 | 120 | 161 | 177 | 201 | 260 | 272 | 328 | 389 | 451 | 598 | 663 | |
CWIP | 5 | 8 | 20 | 10 | 14 | 20 | 18 | 19 | 25 | 21 | 43 | 78 | 95 |
Investments | 7 | 7 | 6 | 6 | 6 | 6 | 18 | 42 | 58 | 385 | 384 | 176 | 212 |
86 | 108 | 137 | 178 | 180 | 222 | 258 | 300 | 330 | 392 | 456 | 686 | 691 | |
Total Assets | 180 | 212 | 282 | 354 | 376 | 449 | 555 | 633 | 740 | 1,187 | 1,334 | 1,538 | 1,662 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
33 | 38 | 65 | 63 | 62 | 55 | 76 | 113 | 127 | 116 | 126 | 195 | |
-26 | -30 | -58 | -57 | -30 | -54 | -87 | -104 | -106 | -434 | -89 | -187 | |
-7 | -8 | 6 | -9 | -31 | -1 | 14 | -10 | -22 | 319 | -40 | -8 | |
Net Cash Flow | 0 | 0 | 13 | -2 | 1 | 0 | 3 | -1 | -1 | 1 | -2 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 57 | 61 | 53 | 58 | 75 | 79 | 81 | 77 | 68 | 73 | 80 | 76 |
Inventory Days | 184 | 144 | 140 | 146 | 105 | 193 | 207 | 138 | 241 | 202 | 210 | 222 |
Days Payable | 125 | 100 | 102 | 103 | 77 | 136 | 130 | 93 | 144 | 104 | 109 | 95 |
Cash Conversion Cycle | 116 | 105 | 91 | 101 | 103 | 136 | 157 | 123 | 165 | 171 | 181 | 203 |
Working Capital Days | 57 | 55 | 31 | 42 | 64 | 82 | 93 | 80 | 70 | 104 | 113 | 108 |
ROCE % | 29% | 27% | 33% | 30% | 26% | 25% | 26% | 23% | 25% | 21% | 16% | 19% |
Documents
Announcements
- Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On Today I.E. 08Th March, 2024 8 Mar
- Closure of Trading Window 4 Mar
- Board Meeting Intimation for Prior Intimation Under Regulation 29(1)(D) Of The SEBI (LODR) Regulations, 2015 And Notice Of Closure Of Trading Window Under Regulation 9 Of The SEBI(Prohibition Of Insider Trading) Regulations, 2015. 4 Mar
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
14 Feb - In continuation od earlier intimation given on 31st January, 2024, pursuant to the provisions of Regulation 30 of the SEBI(LODR) Regulations, 2015, read with Regulation …
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 Feb - Transcript of the Investor Meet/Call held on 02nd February, 2024 at 04:00 P.M(IST) on the Unaudited Financial Results of the Company for the quarter ended …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024TranscriptPPT
-
Nov 2023TranscriptPPT
-
Aug 2023TranscriptPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Aug 2022TranscriptPPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jul 2021TranscriptPPT
-
May 2021Transcript PPT
-
Feb 2021TranscriptNotesPPT
Product Portfolio
The company is a top exporter of plastic medical disposables/ surgical Items.
It has a portfolio of over 130 SKUs of disposable medical devices across 9 different product verticals.[1]